Haverford Trust Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Sell |
|
|||||
|
2025
Q1 | $2.86M | Buy |
|
|||||
|
2024
Q4 | $2.49M | Sell |
|
|||||
|
2024
Q3 | $3.13M | Sell |
|
|||||
|
2024
Q2 | $3M | Sell |
|
|||||
|
2024
Q1 | $3.57M | Sell |
|
|||||
|
2023
Q4 | $3.17M | Sell |
|
|||||
|
2023
Q3 | $3.2M | Sell |
|
|||||
|
2023
Q2 | $3.17M | Sell |
|
|||||
|
2023
Q1 | $3.51M | Buy |
|
|||||
|
2022
Q4 | $3.41M | Sell |
|
|||||
|
2022
Q3 | $2.89M | Buy |
|
|||||
|
2022
Q2 | $5.34M | Sell |
|
|||||
|
2022
Q1 | $5.4M | Sell |
|
|||||
|
2021
Q4 | $5.91M | Buy |
|
|||||
|
2021
Q3 | $5.04M | Sell |
|
|||||
|
2021
Q2 | $5.48M | Sell |
|
|||||
|
2021
Q1 | $11.2M | Sell |
|
|||||
|
2020
Q4 | $11.8M | Sell |
|
|||||
|
2020
Q3 | $12.2M | Sell |
|
|||||
|
2020
Q2 | $14.9M | Buy |
|
|||||
|
2020
Q1 | $13.3M | Sell |
|
|||||
|
2019
Q4 | $16.6M | Sell |
|
|||||
|
2019
Q3 | $16.2M | Sell |
|
|||||
|
2019
Q2 | $15.5M | Sell |
|
|||||
|
2019
Q1 | $16.2M | Buy |
|
|||||
|
2018
Q4 | $14.3M | Sell |
|
|||||
|
2018
Q3 | $15.9M | Sell |
|
|||||
|
2018
Q2 | $37M | Buy |
|
|||||
|
2018
Q1 | $35.2M | Buy |
|
|||||
|
2017
Q4 | $30.8M | Buy |
|
|||||
|
2017
Q3 | $30.2M | Buy |
|
|||||
|
2017
Q2 | $31.9M | Buy |
|
|||||
|
2017
Q1 | $30.7M | Buy |
|
|||||
|
2016
Q4 | $26M | Sell |
|
|||||
|
2016
Q3 | $30.2M | Sell |
|
|||||
|
2016
Q2 | $30.3M | Sell |
|
|||||
|
2016
Q1 | $29.6M | Buy |
|
|||||
|
2015
Q4 | $28.6M | Buy |
|
|||||
|
2015
Q3 | $27.1M | Buy |
|
|||||
|
2015
Q2 | $28.1M | Buy |
|
|||||
|
2015
Q1 | $30.8M | Buy |
|
|||||
|
2014
Q4 | $27.3M | Sell |
|
|||||
|
2014
Q3 | $30.1M | Buy |
|
|||||
|
2014
Q2 | $34.4M | Buy |
|
|||||
|
2014
Q1 | $34M | Sell |
|
|||||
|
2013
Q4 | $36.7M | Buy |
|
|||||
|
2013
Q3 | $33.9M | Buy |
|
|||||
|
2013
Q2 | $33.5M | Buy |
|